PharmCADD Raised USD 16m in Series B Funding

BUSAN, South Korea--(BUSINESS WIRE)--#AI--PharmCADD, a Korean Artificial Intelligence (AI) and Physics-based drug discovery company announced that it has finished USD 16 million series B funding on March 31, 2021. This funding round was led by Strateg...

Full "IntellAsia: Resources" article